Cargando…
Poly-L-Lysine–Lactobionic Acid-Capped Selenium Nanoparticles for Liver-Targeted Gene Delivery
Liver cancer is currently regarded as the second leading cause of cancer-related mortality globally and is the sixth most diagnosed malignancy. Selenium nanoparticles (SeNPs) have attracted favorable attention as nanocarriers for gene therapy, as they possess beneficial antioxidant and anticancer pr...
Autores principales: | Naidoo, Shaigan, Daniels, Aliscia, Habib, Saffiya, Singh, Moganavelli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835765/ https://www.ncbi.nlm.nih.gov/pubmed/35163414 http://dx.doi.org/10.3390/ijms23031492 |
Ejemplares similares
-
Anti-
c-myc cholesterol based lipoplexes as onco-nanotherapeutic agents
in vitro
por: Habib, Saffiya, et al.
Publicado: (2021) -
Folate-Targeted Transgenic Activity of Dendrimer Functionalized Selenium Nanoparticles In Vitro
por: Pillay, Nikita Simone, et al.
Publicado: (2020) -
The Potential of Curcumin-Capped Nanoparticle Synthesis in Cancer Therapy: A Green Synthesis Approach
por: Venkatas, Jeaneen, et al.
Publicado: (2022) -
Angiopep-2-Modified Nanoparticles for Brain-Directed Delivery of Therapeutics: A Review
por: Habib, Saffiya, et al.
Publicado: (2022) -
Dendrimers as Modifiers of Inorganic Nanoparticles for Therapeutic Delivery in Cancer
por: Zenze, Mkhuseli, et al.
Publicado: (2023)